Validation of a derived version of the IPF-specific Saint George’s Respiratory Questionnaire

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,38 MB, PDF-dokument

  • Thomas Skovhus Prior
  • Nils Hoyer
  • Shaker, Saher Burhan
  • Jesper Rømhild Davidsen
  • Ole Hilberg
  • Haridarshan Patel
  • Elisabeth Bendstrup

Background: Health-related quality of life (HRQL) is impaired in patients with idiopathic pulmonary fibrosis (IPF). HRQL is often measured using the St. George’s Respiratory Questionnaire (SGRQ) despite the development of an IPF-specific version (SGRQ-I). Using data from a real-world cohort of patients with IPF, we aimed to transform SGRQ into a derived version of SGRQ-I, SGRQ-Ider, to examine the cross-sectional and longitudinal validity of SGRQ-Ider and to compare SGRQ-Ider to SGRQ-I. Methods: Based on results from SGRQ, SGRQ-Ider was derived applying the algorithm used to develop SGRQ-I. Of the 50 items in SGRQ, 34 items were retained in SGRQ-Ider. Response options for seven items were collapsed and minor adjustments were made to the weights of two items after correspondence with the developers of SGRQ-I. Cross-sectional validation, responsiveness and minimal clinically important difference (MCID) were assessed by comparison to other HRQL instruments, pulmonary function tests and 6-min walk test performed at baseline, 6 and 12 months. Furthermore, the association between SGRQ-Ider scores and mortality was examined. Results: A total of 150 IPF patients participated and 124 completed follow-up at 12 months. SGRQ-Ider performed comparably to SGRQ-I with a high concurrent validity, good test–retest reliability and high known-groups validity. SGRQ-Ider was responsive to change in HRQL and physiological anchors. MCID of SGRQ-Ider for improvement and deterioration was 3.5 and 5.7, respectively. SGRQ-Ider scores were associated with mortality in both univariate (HR 1.82, 95% CI 1.42–2.34 per 20-point increase) and multivariate analyses (HR 1.57, 95% CI 1.20–2.05 per 20-point increase). Conclusions: The SGRQ-Ider is a valid, reliable and responsive HRQL instrument in patients with IPF and has psychometric properties comparable to SGRQ-I. Thus, SGRQ results can reliably be transformed into the SGRQ-Ider. The MCID estimates were calculated for improvement and deterioration separately. Increasing SGRQ-Ider score was associated with increased mortality.

OriginalsprogEngelsk
Artikelnummer259
TidsskriftRespiratory research
Vol/bind22
Udgave nummer1
Sider (fra-til)1-10
ISSN1465-9921
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
For the current work, TSP has received an unrestricted grant from Boehringer Ingelheim and TSP and HP have received personal fees from Galapagos. Outside the current work, TSP has received personal fees from Boehringer Ingelheim, JRD has received personal fees and non-financial support from Boehringer Ingelheim and Roche, and EB has received personal fees from Galapagos and personal fees and grants from Boehringer Ingelheim and Roche. NH, OH, and SBS have nothing to declare.

Funding Information:
The study was supported by Grants from Galapagos, TrygFonden (Grant 118860), Aarhus University (unrestricted), Boehringer Ingelheim Denmark (unrestricted), the Danish Lung Association’s Fund, the Health Research Fund of the Central Denmark Region and the Ellen and Knud Dalhoff Larsen’s Fund. The funders of the study had no role in study design, data collection, data analyses, data interpretation, writing of the report or decision to submit the paper for publication.

Publisher Copyright:
© 2021, The Author(s).

ID: 304748629